Point72 Asset Management »

Zentalis Pharmaceuticals shares owned by Point72 Asset Management

Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Point72 Asset Management from 13F filings

Historical chart of Point72 Asset Management investment in Zentalis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Zentalis Pharmaceuticals held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zentalis Pharmaceuticals by Point72 Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $222k 95k 2.34
2025-12-31 $135k 100k 1.35

More positions owned by Point72 Asset Management

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Arista Networks Com Shs (ANET)
Asml Hldg Nv N Y Registry Shs (ASML)
Broadcom (AVGO)
Credo Technology Group Holdi Ordinary Shares (CRDO)
Teradyne (TER)
Meta Platforms Cl A (META)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Applied Materials (AMAT)
Spotify Technology S A SHS (SPOT)
Equinix (EQIX)
Home Depot (HD)

View all positions for Point72 Asset Management

Top funds holding Zentalis Pharmaceuticals

Squadron Capital Management
5AM Venture Management
Two Sigma Investments
Acadian Asset Management
Vanguard Capital Management
Renaissance Technologies
Citadel Advisors
D. E. Shaw & Co
Opaleye Management
Decheng Capital
Millennium Management
BlackRock
Bank of America Corporation
PRIMECAP Management Company
Pfizer

View all funds holding Zentalis Pharmaceuticals